The Evolving Landscape of PD-1/PD-L1 Pathway in Head and Neck Cancer

Over the past 10 years, cancer immunotherapy has made significant progress in multiple cancer types and has been gradually been applied to clinical cancer care, in which the programmed cell death protein-1 (PD-1)/programmed cell death ligand 1 (PD-L1) pathway is one of the most attractive targets. C...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Immunol
Autori principali: Qiao, Xin-wei, Jiang, Jian, Pang, Xin, Huang, Mei-chang, Tang, Ya-jie, Liang, Xin-hua, Tang, Ya-ling
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2020
Soggetti:
Immunology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7531035/
https://ncbi.nlm.nih.gov/pubmed/33072064
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.01721
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi